INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 273 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $210,131 | -53.5% | 4,034 | -43.4% | 0.00% | – |
| Q2 2023 | $451,534 | +34.4% | 7,131 | +15.0% | 0.00% | – |
| Q1 2023 | $335,838 | +8.0% | 6,202 | +5.6% | 0.00% | – |
| Q4 2022 | $310,905 | +0.3% | 5,875 | -11.8% | 0.00% | – |
| Q3 2022 | $310,000 | -7.7% | 6,659 | +13.1% | 0.00% | – |
| Q2 2022 | $336,000 | -7.4% | 5,890 | -0.3% | 0.00% | – |
| Q1 2022 | $363,000 | +47.6% | 5,909 | +25.6% | 0.00% | – |
| Q4 2021 | $246,000 | +103.3% | 4,705 | +45.5% | 0.00% | – |
| Q3 2021 | $121,000 | +40.7% | 3,233 | +54.2% | 0.00% | – |
| Q2 2021 | $86,000 | +3.6% | 2,096 | -13.3% | 0.00% | – |
| Q1 2021 | $83,000 | +1.2% | 2,417 | -5.0% | 0.00% | – |
| Q4 2020 | $82,000 | +24.2% | 2,545 | 0.0% | 0.00% | – |
| Q3 2020 | $66,000 | +15.8% | 2,545 | +14.4% | 0.00% | – |
| Q2 2020 | $57,000 | +62.9% | 2,224 | 0.0% | 0.00% | – |
| Q1 2020 | $35,000 | -54.5% | 2,224 | 0.0% | 0.00% | – |
| Q4 2019 | $77,000 | +413.3% | 2,224 | +7.6% | 0.00% | – |
| Q3 2019 | $15,000 | -44.4% | 2,066 | -4.4% | 0.00% | – |
| Q2 2019 | $27,000 | +12.5% | 2,161 | +4.6% | 0.00% | – |
| Q1 2019 | $24,000 | +4.3% | 2,066 | 0.0% | 0.00% | – |
| Q4 2018 | $23,000 | -48.9% | 2,066 | 0.0% | 0.00% | – |
| Q3 2018 | $45,000 | +21.6% | 2,066 | 0.0% | 0.00% | – |
| Q2 2018 | $37,000 | +1750.0% | 2,066 | +3030.3% | 0.00% | – |
| Q1 2018 | $2,000 | – | 66 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 66 | -99.8% | 0.00% | -100.0% |
| Q3 2016 | $541,000 | -61.7% | 35,482 | -2.4% | 0.00% | -50.0% |
| Q2 2016 | $1,411,000 | +6.2% | 36,367 | -23.9% | 0.00% | 0.0% |
| Q1 2016 | $1,329,000 | +1771.8% | 47,810 | +3492.0% | 0.00% | – |
| Q4 2015 | $71,000 | +26.8% | 1,331 | -4.9% | 0.00% | – |
| Q3 2015 | $56,000 | – | 1,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |